SEC Form 4 · accession 0001078782-17-001584
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Nov 9, 2017
Accepted (ET)
Nov 14, 2017 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 9, 2017 | P | 52,000 | $0.07 | A | 13,754,831 | D | |
| Common Stock | Nov 10, 2017 | P | 41,000 | $0.08 | A | 13,795,831 | D |
Table II — derivative securities
No Table II lines on this filing.